FDLI – Introduction to Drug, Biologics, and Biosimilars Law and Regulation

Latham lawyer Eitan Bernstein will present on the FDA Regulatory Process at the FDLI's first program in Boston.

The regulation of pharmaceutical and biological products often overlaps. This course will provide a comprehensive understanding of the administrative agencies that impact these industries, which FDA center regulates, depending on the product, and how they interact.

Learn about the development of drug and biological products, FDA’s review and approval of marketing applications, generic drugs and biosimilars, manufacturing issues, advertising and promotion, and related issues. Case studies, hypotheticals, and ample time for Q&A is provided.

For more information, visit the event website.

If you would like to attend, please email Kimberly Alexander for a discounted registration code.

Cities & Dates

Boston, MA, US
July 23, 2019

Duane Morris LLP
100 High Street
Suite 2400


Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.